Literature DB >> 17049193

Seizures and electroencephalographic findings in CDKL5 mutations: case report and review.

S Grosso1, A Brogna, S Bazzotti, A Renieri, G Morgese, P Balestri.   

Abstract

Mutations in the X-linked gene cyclin-dependent kinase-like 5 (CDKL5) have been detected in patients presenting with seizures in the first few months of life and Rett syndrome features. Twenty-seven cases have been detected to date. Generalized intractable seizures, as infantile spasms, and generalized tonic-clonic seizures and myoclonic seizures characterize the clinical picture of CDKL5 mutations. Here we report on a patient who presented with sleep-related hyperkinetic seizures. Our observation and review of the literature suggest that a broader polymorphic electroclinical pattern with both generalized and focal seizures may occur in patients with CDKL5 mutations. A screen for CDKL5 mutations is useful in patients, mainly females, with a history of early onset intractable seizures and becomes mandatory when idiopathic infantile spasms and/or atypical Rett syndrome features are also present.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049193     DOI: 10.1016/j.braindev.2006.09.001

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  10 in total

1.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.

Authors:  Stephanie Fehr; Meredith Wilson; Jenny Downs; Simon Williams; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Gladys Ho; Roberta Polli; Stavroula Psoni; Xinhua Bao; Nick de Klerk; Helen Leonard; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-08-08       Impact factor: 4.246

Review 2.  Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.

Authors:  Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-02-23       Impact factor: 3.372

3.  Progressive EEG Changes in CDKL-5 Related Epileptic Encephalopathy.

Authors:  Bhanudeep Singanamalla; Arvind Kumar Singh; Arushi Gahlot Saini
Journal:  Indian J Pediatr       Date:  2020-01-16       Impact factor: 1.967

4.  CDKL5-Related Disorders: From Clinical Description to Molecular Genetics.

Authors:  N Bahi-Buisson; T Bienvenu
Journal:  Mol Syndromol       Date:  2011-09-13

Review 5.  CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.

Authors:  William Hong; Isabel Haviland; Elia Pestana-Knight; Judith L Weisenberg; Scott Demarest; Eric D Marsh; Heather E Olson
Journal:  CNS Drugs       Date:  2022-05-28       Impact factor: 6.497

Review 6.  The role of epilepsy and epileptiform EEGs in autism spectrum disorders.

Authors:  Sarah J Spence; Mark T Schneider
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756

7.  Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes.

Authors:  S Russo; M Marchi; F Cogliati; M T Bonati; M Pintaudi; E Veneselli; V Saletti; M Balestrini; B Ben-Zeev; L Larizza
Journal:  Neurogenetics       Date:  2009-02-25       Impact factor: 2.660

8.  Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.

Authors:  Patrick J Mulcahey; Sheng Tang; Hajime Takano; Alicia White; Dayana R Davila Portillo; Owen M Kane; Eric D Marsh; Zhaolan Zhou; Douglas A Coulter
Journal:  Exp Neurol       Date:  2020-06-22       Impact factor: 5.620

9.  Epilepsy and genetic in Rett syndrome: A review.

Authors:  Francesca Felicia Operto; Roberta Mazza; Grazia Maria Giovanna Pastorino; Alberto Verrotti; Giangennaro Coppola
Journal:  Brain Behav       Date:  2019-03-30       Impact factor: 2.708

10.  Mapping pathological phenotypes in a mouse model of CDKL5 disorder.

Authors:  Elena Amendola; Yang Zhan; Camilla Mattucci; Enrico Castroflorio; Eleonora Calcagno; Claudia Fuchs; Giuseppina Lonetti; Davide Silingardi; Alexei L Vyssotski; Dominika Farley; Elisabetta Ciani; Tommaso Pizzorusso; Maurizio Giustetto; Cornelius T Gross
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.